Gastrointestinal Bleeding on Continuous-Flow Left Ventricular Assist Device Therapy
ESC Heart Failure · 01.08.2023 · 10 (4) · 2214-2224
DOI: 10.1002/ehf2.14433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ESC Heart Failure, online erschienen am 15.06.2023. Verfasst von Yoav Hammer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Disease, Michigan Medicine - University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
While technological advances in the field of continuous-flow left ventricular assist device (CF-LVAD) are constantly being made, CF-LVAD recipients are still subjected to a relatively high rate of LVAD-related adverse events, with post-LVAD gastrointestinal bleeding (GIB) being the most common one. GIB is associated with a significant impairment in quality of life, multiple hospital admissions, blood transfusion requirements and possibly death. Furthermore, of those patients who bled once, many will experience recurrent GIB events, which further aggravates their discomfort. While some medical and endoscopic treatment options are available, evidence regarding their benefit remains largely equivocal, with all related studies based on data from registries rather than clinical trials. Although having a major impact on LVAD recipients, an effective and validated pre-implant screening options to predict GIB events post-implant are scarce. This review focuses on the aetiology, incidence, risk factors, treatment options and the effect of new generation devices on post-LVAD GIB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Disease, Michigan Medicine - University of Michigan, Ann Arbor, MI, USA.
Zitieren
APA
Hammer, Y., Bitar, A., & Aaronson, K. D. (2023). Gastrointestinal Bleeding on Continuous-Flow Left Ventricular Assist Device Therapy. ESC Heart Failure, 10(4), 2214-2224. https://doi.org/10.1002/ehf2.14433
Vancouver
Hammer Y, Bitar A, Aaronson KD. Gastrointestinal Bleeding on Continuous-Flow Left Ventricular Assist Device Therapy. ESC Heart Failure. 2023;10(4):2214-2224. doi:10.1002/ehf2.14433
BibTeX
@article{Hammer2023,
author = {Hammer, Yoav and Bitar, Abbas and Aaronson, Keith D},
title = {Gastrointestinal Bleeding on Continuous-Flow Left Ventricular Assist Device Therapy},
journal = {ESC Heart Failure},
year = {2023},
volume = {10},
number = {4},
pages = {2214--2224},
doi = {10.1002/ehf2.14433}
}
EUVIMED